Results 61 to 70 of about 1,204,526 (212)
Mucopolysaccharidosis type IIIC (MPSIIIC) is a severe lysosomal storage disease caused by deficiency in activity of the transmembrane enzyme heparan-α-glucosaminide N-acetyltransferase (HGSNAT) that catalyses the N-acetylation of α-glucosamine residues ...
Sara Marcó +14 more
doaj +1 more source
Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells [PDF]
Xinhong Zhu +8 more
openalex +1 more source
The joint battle to tackle epidermolysis bullosa through gene therapy
Laura De Rosa, Michele De Luca
openalex +2 more sources
Preclinical animal models are indispensable for uncovering disease mechanisms and developing novel therapeutic interventions in synucleinopathies. Key readouts including neuronal cell death, neuroinflammation and alpha-synuclein protein aggregation, are ...
A. Barber-Janer +7 more
doaj +1 more source
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
Reetta A. E. Eriksson +16 more
doaj +1 more source
Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment [PDF]
Cian M. McCrudden +8 more
openalex +1 more source
Approved gene therapies in Australia: coming to a store near you
Shreyashee Mallik +2 more
openalex +1 more source
Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone [PDF]
Carl K. Edwards
openalex +1 more source

